tiprankstipranks
Kobayashi Pharmaceutical Co Ltd (KBYPF)
OTHER OTC:KBYPF
Holding KBYPF?
Track your performance easily

Kobayashi Pharmaceutical Co (KBYPF) Financial Statements

5 Followers

Kobayashi Pharmaceutical Co Financial Overview

Kobayashi Pharmaceutical Co's market cap is currently ―. The company's EPS TTM is $0.916; its P/E ratio is 40.72; and it has a dividend yield of 1.79%. Kobayashi Pharmaceutical Co is scheduled to report earnings on January 31, 2025, and the estimated EPS forecast is $0.51. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue¥ 51.98B¥ 43.02B¥ 38.62B¥ 32.65B¥ 47.59B
Gross Profit¥ 26.97B¥ 24.43B¥ 22.29B¥ 18.64B¥ 25.36B
EBIT¥ 7.58B¥ 9.51B¥ 5.77B¥ 5.10B¥ 6.75B
EBITDA¥ 7.58B¥ 9.51B¥ 5.77B¥ 5.10B¥ 6.75B
Net Income Common Stockholders¥ 5.52B¥ 6.80B¥ 4.23B¥ 3.47B¥ 4.83B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 104.53B¥ 105.26B¥ 116.15B¥ 107.66B¥ 109.05B
Total Assets¥ 255.83B¥ 255.58B¥ 250.82B¥ 242.41B¥ 252.55B
Total Debt¥ 792.00M¥ 549.00M¥ 596.00M¥ 617.00M¥ 630.00M
Net Debt¥ -103.74B¥ -104.72B¥ -115.55B¥ -107.04B¥ -108.42B
Total Liabilities¥ 57.93B¥ 50.59B¥ 51.41B¥ 50.04B¥ 56.95B
Stockholders Equity¥ 197.90B¥ 204.99B¥ 199.41B¥ 192.37B¥ 195.60B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in JPY

Kobayashi Pharmaceutical Co Earnings and Revenue History

Kobayashi Pharmaceutical Co Debt to Assets

Kobayashi Pharmaceutical Co Cash Flow

Kobayashi Pharmaceutical Co Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis